Gene expression profiling in lymphoma diagnosis and management

Best Practice and Research: Clinical Haematology

Volumn 22, Issue 2, 2009, Pages 191-210

  Iqbal, Javeed ^a   Liu, ZhongFeng ^a   Deffenbacher, Karen ^a   Chan, Wing C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

diffuse large B cell lymphomas; gene expression profiling; molecular classification; molecular prognosis; peripheral T cell lymphoma; targeted therapy

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMATINIB; PREDNISOLONE; RITUXIMAB; VASCULOTROPIN INHIBITOR; VINCRISTINE;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER GENETICS; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; T CELL LYMPHOMA; TRANSCRIPTOMICS;

COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 68749087282     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2009.05.001     Document Type: Review

References (115)

1. Rappaport H. Tumors of the hematopoietic system. Atlas of tumour pathlogy (1966), AFIP Section III
2. Lukes R.J., and Collins R.D. Immunologic characterization of human malignant lymphomas. Cancer 34 4 Suppl (1974) suppl:1488-1503
3. Stansfeld A.G., Diebold J., Noel H., et al. Updated Kiel classification for lymphomas. Lancet 1 8580 (1988) 292-293
4. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 49 (1982) 2112-2135
5. Swerdlow S.H., Campo E., Harris N.L., et al. WHO classification: pathology and genetics of tumors of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France
6. Pearson P.L., and Van der Luijt R.B. The genetic analysis of cancer. J Intern Med 243 6 (1998) 413-417
7. Knudson A.G. Hereditary predisposition to cancer. Ann N Y Acad Sci 833 (1997) 58-67
8. Saluz H.P., Iqbal J., Gino V.L., et al. Fundamentals of DNA-chip/array technology for comparative gene-expression analysis. Curr Sci 83 (2002) 829-833
9. Sherlock G. Analysis of large-scale gene expression data. Curr Opin Immunol 12 2 (2000) 201-205
10. BRB-ArrayTools user guide, version 3.6.0. Available from:. http://linus.nci.nih.gov/BRB-ArrayTools.html
11. Simon R. Microarray-based expression profiling and informatics. Curr Opin Biotechnol 19 1 (2008) 26-29
12. Shi L., Reid L.H., Jones W.D., et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24 9 (2006) 1151-1161
13. Shendure J., and Ji H. Next-generation DNA sequencing. Nat Biotechnol 26 10 (2008) 1135-1145
14. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 6769 (2000) 503-511
15. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 25 (2002) 1937-1947
16. Lenz G., Wright G., Dave S.S., et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359 22 (2008) 2313-2323
17. Monti S., Savage K.J., Kutok J.L., et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105 5 (2005) 1851-1861
18. Rosenwald A., Wright G., Leroy K., et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198 6 (2003) 851-862
19. Savage K.J., Monti S., Kutok J.L., et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102 12 (2003) 3871-3879
20. Fujii A., Ohshima K., Hamasaki M., et al. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma. Int J Oncol 24 3 (2004) 529-538
21. Hoefnagel J.J., Dijkman R., Basso K., et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105 9 (2005) 3671-3678
22. Kobayashi T., Yamaguchi M., Kim S., et al. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas. Cancer Res 63 1 (2003) 60-66
23. Klein U., Gloghini A., Gaidano G., et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101 10 (2003) 4115-4121
24. Fan W., Bubman D., Chadburn A., et al. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 79 2 (2005) 1244-1251
25. Rosenwald A., Wright G., Wiestner A., et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3 2 (2003) 185-197
26. Fu K., Weisenburger D.D., Greiner T.C., et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106 13 (2005) 4315-4321
27. Wlodarska I., Dierickx D., Vanhentenrijk V., et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 111 12 (2008) 5683-5690
28. Dave S.S., Wright G., Tan B., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351 21 (2004) 2159-2169
29. d'Amore F., Chan E., Iqbal J., et al. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res 14 22 (2008) 7180-7187
30. Yano T., Jaffe E.S., Longo D.L., et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood 80 3 (1992) 758-767
31. Sander C.A., Yano T., Clark H.M., et al. p53 mutation is associated with progression in follicular lymphomas. Blood 82 7 (1993) 1994-2004
32. Matolcsy A., Casali P., Warnke R.A., et al. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 88 10 (1996) 3937-3944
33. Elenitoba-Johnson K.S., Gascoyne R.D., Lim M.S., et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91 12 (1998) 4677-4685
34. Pinyol M., Cobo F., Bea S., et al. p16 (INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 91 8 (1998) 2977-2984
35. Lossos I.S., Alizadeh A.A., Diehn M., et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A 99 13 (2002) 8886-8891
36. Martinez-Climent J.A., Alizadeh A.A., Segraves R., et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101 8 (2003) 3109-3117
37. Elenitoba-Johnson K.S., Jenson S.D., Abbott R.T., et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A 100 12 (2003) 7259-7264
38. Thieblemont C., Nasser V., Felman P., et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 103 7 (2004) 2727-2737
39. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89 11 (1997) 3909-3918
40. Rudiger T., Weisenburger D.D., Anderson J.R., et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13 1 (2002) 140-149
41. Reiser M., Josting A., Soltani M., et al. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma 43 4 (2002) 805-811
42. Vose J.M. International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathology Review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood 106 (2005) 811a
43. International peripheral T-cell and natural killer/t-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26 25 (2008) 4124-4130
44. de Leval L., Rickman D.S., Thielen C., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109 11 (2007) 4952-4963
45. Martinez-Delgado B. Peripheral T-cell lymphoma gene expression profiles. Hematol Oncol 24 3 (2006) 113-119
46. Piccaluga P.P., Agostinelli C., Califano A., et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67 22 (2007) 10703-10710
47. Piccaluga P.P., Agostinelli C., Califano A., et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 117 3 (2007) 823-834
48. Yu D., Tan A.H., Hu X., et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450 7167 (2007) 299-303
49. Weiss L.M., Jaffe E.S., Liu X.F., et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79 7 (1992) 1789-1795
50. Rutella S., Danese S., and Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108 5 (2006) 1435-1440
51. Hwu P., Du M.X., Lapointe R., et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164 7 (2000) 3596-3599
52. Kuhn R., Lohler J., Rennick D., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 2 (1993) 263-274
53. Sundrud M.S., and Rao A. New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT. Curr Opin Immunol 19 3 (2007) 287-293
54. Dupuis J., Boye K., Martin N., et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30 4 (2006) 490-494
55. Martinez-Delgado B., Cuadros M., Honrado E., et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 19 12 (2005) 2254-2263
56. Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 5151 (1994) 1281-1284 New York, NY
57. Rimokh R., Magaud J.P., Berger F., et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 71 1 (1989) 31-36
58. Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 267 5196 (1995) 316-317 New York, NY
59. Morris S.W., Xue L., Ma Z., et al. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. Br J Haematol 113 2 (2001) 275-295
60. Slupianek A., Nieborowska-Skorska M., Hoser G., et al. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res 61 5 (2001) 2194-2199
61. Zhang Q., Wang H.Y., Liu X., et al. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nat Med 13 11 (2007) 1341-1348
62. Piva R., Pellegrino E., Mattioli M., et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest 116 12 (2006) 3171-3182
63. Bohling S.D., Jenson S.D., Crockett D.K., et al. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma. Leuk Res 32 3 (2008) 383-393
64. Gaiser T., Thorns C., Merz H., et al. Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays. J Hematother Stem Cell Res 11 2 (2002) 423-428
65. Foss H.D., Anagnostopoulos I., Araujo I., et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88 10 (1996) 4005-4011
66. Bonzheim I., Geissinger E., Roth S., et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 104 10 (2004) 3358-3360
67. Salaverria I., Bea S., Lopez-Guillermo A., et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 140 5 (2008) 516-526
68. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24 39 (2005) 6058-6068
69. Franchini G., Nicot C., and Johnson J.M. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res 89 (2003) 69-132
70. Azran I., Schavinsky-Khrapunsky Y., and Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 1 (2004) 20
71. Gatza M.L., Watt J.C., and Marriott S.J. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22 33 (2003) 5141-5149
72. Sasaki H., Nishikata I., Shiraga T., et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105 3 (2005) 1204-1213
73. Pise-Masison C.A., Radonovich M., Dohoney K., et al. Gene expression profiling of ATL patients: compilation of disease related genes and evidence for TCF-4 involvement in BIRC5 gene expression and cell viability. Blood (2009)
74. Ballester B., Ramuz O., Gisselbrecht C., et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25 10 (2006) 1560-1570
75. Nelson M., Horsman D.E., Weisenburger D.D., et al. Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. Br J Haematol 141 4 (2008) 461-469
76. Cuadros M., Dave S.S., Jaffe E.S., et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 25 22 (2007) 3321-3329
77. Haque T., Faury D., Albrecht S., et al. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma. Clin Cancer Res 13 21 (2007) 6284-6292
78. Maciejewski J.P., and Mufti G.J. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 112 4 (2008) 965-974
79. Kallioniemi O.P., Kallioniemi A., Sudar D., et al. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 4 1 (1993) 41-46
80. Pinkel D., and Albertson D.G. Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 Suppl (2005) S11-S17
81. Ishkanian A.S., Malloff C.A., Watson S.K., et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36 3 (2004) 299-303
82. Affymetrix I. High-resolution chromosome copy number analysis using GeneChip mapping arrays. Affymetrix Product Family GeneChip Chromosome Copy Number Analysis Tool 2005.
83. Strefford J.C., Worley H., Barber K., et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 26 29 (2007) 4306-4318
84. Lenz G., Wright G.W., Emre N.C., et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105 36 (2008) 13520-13525
85. Iqbal J, Can Kucuk, DeLeeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia, in press [online publication 5 February 2009, doi:10.1038/leu.2009.3].
86. Eulalio A., Huntzinger E., and Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 132 1 (2008) 9-14
87. Garzon R., and Croce C.M. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15 4 (2008) 352-358
88. Malumbres R., Sarosiek K.A., Cubedo E., et al. Differentiation-stage-specific expression of microRNAs in B-lymphocytes and diffuse large B-cell lymphomas. Blood (2008)
89. Zhang J., Jima D.D., Jacobs C., et al. Patterns of microRNA expression characterize stages of human B cell differentiation. Blood (2009)
90. Lawrie C.H., Saunders N.J., Soneji S., et al. MicroRNA expression in lymphocyte development and malignancy. Leukemia 22 7 (2008) 1440-1446
91. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101 9 (2004) 2999-3004
92. Tam W., Ben-Yehuda D., and Hayward W.S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17 3 (1997) 1490-1502
93. Eis P.S., Tam W., Sun L., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102 10 (2005) 3627-3632
94. Kluiver J., Haralambieva E., de Jong D., et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45 2 (2006) 147-153
95. Calin G.A., Ferracin M., Cimmino A., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353 17 (2005) 1793-1801
96. Pasqualucci L., Migliazza A., Fracchiolla N., et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 95 20 (1998) 11816-11821
97. Young K.H., Weisenburger D.D., Dave B.J., et al. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood 110 13 (2007) 4396-4405
98. Tam W., Gomez M., Chadburn A., et al. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107 10 (2006) 4090-4100
99. Pasqualucci L., Compagno M., Houldsworth J., et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203 2 (2006) 311-317
100. Lenz G., Davis R.E., Ngo V.N., et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319 5870 (2008) 1676-1679 New York, NY
101. Novak U., Rinaldi A., Kwee I., et al. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas. Blood (2009)
102. Zhang Q., Siebert R., Yan M., et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14) (p22;q32). Nat Genet 22 1 (1999) 63-68
103. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet 24 3 (2008) 133-141
104. Martin-Subero J.I., Kreuz M., Bibikova M., et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic and transcriptional profiling. Blood 113 11 (2009) 2488-2497
105. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 310 (2006) 251-274
106. Boultwood J., and Wainscoat J.S. Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138 1 (2007) 3-11
107. Pike B.L., Greiner T.C., Wang X., et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22 5 (2008) 1035-1043
108. Davis R.E., Brown K.D., Siebenlist U., et al. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194 12 (2001) 1861-1874
109. Bild A.H., Yao G., Chang J.T., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 7074 (2006) 353-357
110. Cerchietti L.C., Yang S.N., Shaknovich R., et al. A peptomimetic inhibitor of BCL6 with potent anti-lymphoma effects in vitro and in vivo. Blood (2008)
111. ®) in patients with relapsed/refractory T-cell lymphoma: preliminary results. Blood (2006) 108a
112. Piccaluga P.P., Agostinelli C., Zinzani P.L., et al. Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol 6 6 (2005) 440
113. Malumbres R., Chen J., Tibshirani R., et al. Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Blood 111 12 (2008) 5509-5514
114. Roberts R.A., Sabalos C.M., LeBlanc M.L., et al. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma. Lab Invest 87 10 (2007) 979-997
115. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 1 (2004) 275-282